LaserGen

LaserGen

A biotechnology company focused on commercializing novel technologies for DNA sequencing. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD162m (Public information from Apr 2018)
Houston Texas (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$5.0m

Series A

$80.0m

Series B

$105m

Valuation: $105m

Acquisition
Total FundingAUD131m

Recent News about LaserGen

Edit
More about LaserGeninfo icon
Edit

Lasergen, now part of Agilent, specializes in developing and building innovative life science instrumentation. The company serves clinical diagnostics labs and life science research facilities, offering a range of products including the K6460 LC MS system, which is a fully validated and easily implemented solution for clinical diagnostics. Lasergen operates in the life sciences market, focusing on enhancing lab productivity and providing comprehensive solutions for glycan analysis and cell analysis platforms. The business model revolves around selling advanced scientific instruments and providing technical expertise through webinars and other educational resources. Revenue is generated through the sale of these high-performance instruments and related services.

Keywords: life science instrumentation, clinical diagnostics, research labs, LC MS system, glycan analysis, cell analysis, lab productivity, technical expertise, scientific instruments, Agilent.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.